RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2013

Total Value: $958M (100.0% shares, 0.0% debt)

Holdings (39)

ACAD ACADIA PHARMACEUTICALS INC 15.1%
Value $144M Shares 5,250,000 Est. Cost $13.77 Unrealized +51.8%
DYAX CORP 7.5%
Value $71.47M Shares 10,418,379 Est. Cost $3.46 Unrealized
NOVAVAX INC 6.8%
Value $65.52M Shares 20,800,000 Est. Cost $2.24 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.8%
Value $55.91M Shares 2,035,510 Est. Cost $13.77 Unrealized +51.8%
THERAPEUTICSMD INC 5.1%
Value $48.43M Shares 16,528,641 Est. Cost $3.00 Unrealized
INSM INSMED INC 4.9%
Value $46.57M Shares 2,983,319 Est. Cost $10.68 Unrealized +18.9%
SGMO SANGAMO BIOSCIENCES INC 4.7%
Value $44.67M Shares 4,258,244 Est. Cost $8.72 Unrealized +13.8%
ACHILLION PHARMACEUTICALS IN 4.6%
Value $43.66M Shares 14,457,061 Est. Cost $5.68 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 4.4%
Value $42.55M Shares 5,844,700 Est. Cost $5.07 Unrealized 0.0%
NEWLINK GENETICS CORP 3.6%
Value $34.56M Shares 1,840,294 Est. Cost $19.72 Unrealized
PRTA PROTHENA CORP PLC 3.5%
Value $33.31M Shares 1,646,399 Est. Cost $15.16 Unrealized +16.7%
SGMO SANGAMO BIOSCIENCES INC 3.3%
Value $31.47M Shares 3,000,000 Est. Cost $8.72 Unrealized +13.8%
XOMA CORP DEL 3.2%
Value $31.05M Shares 6,915,525 Est. Cost $3.66 Unrealized
DERMA SCIENCES INC 2.6%
Value $24.7M Shares 1,994,876 Est. Cost $13.35 Unrealized
SUNESIS PHARMACEUTICALS INC 2.5%
Value $24.15M Shares 4,869,261 Est. Cost $5.18 Unrealized
KERYX BIOPHARMACEUTICALS INC 2.5%
Value $24.13M Shares 2,391,261 Est. Cost $7.47 Unrealized
HYPERION THERAPEUTICS INC 2.5%
Value $23.59M Shares 902,858 Est. Cost $22.00 Unrealized
CHEMOCENTRYX INC 1.8%
Value $16.93M Shares 3,045,380 Est. Cost $5.56 Unrealized
ACHILLION PHARMACEUTICALS IN 1.7%
Value $16.61M Shares 5,500,000 Est. Cost $5.68 Unrealized
BLUEBIRD BIO INC 1.3%
Value $12.6M Shares 467,418 Est. Cost $26.96 Unrealized
ROCKWELL MED INC 1.2%
Value $11.4M Shares 1,000,000 Est. Cost Unrealized
MYGN MYRIAD GENETICS INC 1.1%
Value $10.57M Shares 450,000 Est. Cost $28.41 Unrealized 0.0%
OMER OMEROS CORP 1.1%
Value $10.29M Shares 1,055,311 Est. Cost $4.61 Unrealized +29.3%
KERYX BIOPHARMACEUTICALS INC 1.1%
Value $10.09M Shares 1,000,000 Est. Cost $7.47 Unrealized
AMPIO PHARMACEUTICALS INC 1.0%
Value $9.942M Shares 1,325,566 Est. Cost $7.50 Unrealized
NEWLINK GENETICS CORP 1.0%
Value $9.39M Shares 500,000 Est. Cost $19.72 Unrealized
ENZO BIOCHEM INC 0.9%
Value $8.437M Shares 3,348,029 Est. Cost $2.08 Unrealized
MIRATI THERAPEUTICS INC 0.9%
Value $8.359M Shares 551,723 Est. Cost $15.15 Unrealized
DYNAVAX TECHNOLOGIES CORP 0.7%
Value $7.14M Shares 6,000,000 Est. Cost $1.10 Unrealized
ONCOGENEX PHARMACEUTICALS IN 0.7%
Value $7.076M Shares 763,332 Est. Cost $9.80 Unrealized
CORONADO BIOSCIENCES INC 0.7%
Value $7.011M Shares 1,000,000 Est. Cost Unrealized
PTCT PTC THERAPEUTICS INC 0.7%
Value $6.438M Shares 300,000 Est. Cost $17.38 Unrealized 0.0%
ARROWHEAD RESH CORP 0.5%
Value $5.005M Shares 879,561 Est. Cost $2.00 Unrealized
DYAX CORP 0.4%
Value $3.43M Shares 500,000 Est. Cost $3.46 Unrealized
TGTX TG THERAPEUTICS INC 0.3%
Value $3.024M Shares 600,000 Est. Cost $6.12 Unrealized 0.0%
AGIO AGIOS PHARMACEUTICALS INC 0.2%
Value $1.957M Shares 70,000 Est. Cost $27.61 Unrealized 0.0%
OCERA THERAPEUTICS INC 0.2%
Value $1.83M Shares 215,999 Est. Cost $8.47 Unrealized
EPIZYME INC 0.0%
Value $400K Shares 10,000 Est. Cost $28.13 Unrealized
SAVIENT PHARMACEUTICALS INC 0.0%
Value $193K Shares 1,000,000 Est. Cost $0.23 Unrealized